newsfilter
← Latest News
GlobeNewswire·

BREAKING: ADMA Biologics Shares Fall Over 24%; Investors Encouraged to Contact Block & Leviton to Possibly Recover Losses

BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ADMA Biologics, Inc. (NASDAQ:ADMA) for potential securities law violations. Investors who have lost money in their ADMA Biologics, Inc.